The company is developing drugs to treat inflammatory and immunological diseases.
The Berlin-based fund has more than $100 million to deploy, with a focus on cloud software and companies that digitize services.
The firm raised its sights for its ninth main pool even as peers have reined in their fundraising ambitions
The sports-merchandising company raised about $700 million from a group of investors, including Clearlake Capital, Silver Lake and SoftBank.
